GH Research PLC (GHRS)
NASDAQ: GHRS · Real-Time Price · USD
13.50
-0.34 (-2.46%)
At close: Aug 29, 2025, 4:00 PM
13.23
-0.27 (-2.00%)
After-hours: Aug 29, 2025, 5:50 PM EDT
GH Research Market Cap
GH Research has a market cap or net worth of $837.40 million as of August 29, 2025. Its market cap has increased by 63.57% in one year.
Market Cap
837.40M
Enterprise Value
529.36M
1-Year Change
63.57%
Ranking
Category
Stock Price
$13.50
Market Cap Chart
Since the IPO on June 25, 2021, GH Research's market cap has increased from $808.33M to $837.40M, an increase of 3.60%. That is a compound annual growth rate of 0.85%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 29, 2025 | 837.40M | 129.93% |
| Dec 31, 2024 | 364.20M | 20.71% |
| Dec 29, 2023 | 301.72M | -40.33% |
| Dec 30, 2022 | 505.64M | -58.34% |
| Dec 31, 2021 | 1.21B | 50.14% |
| Jun 25, 2021 | 808.33M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 660.76B |
| Johnson & Johnson | 425.05B |
| AbbVie | 368.08B |
| UnitedHealth Group | 272.09B |
| AstraZeneca | 248.21B |
| Novartis AG | 243.97B |
| Novo Nordisk | 243.46B |
| Abbott Laboratories | 229.03B |